CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes | −1,273 | $60.74 | $77K | 156,268 |
| 2026-08-31 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,862 | $60.74 | $174K | 450,385 |
| 2026-08-31 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,273 | $60.74 | $77K | 103,903 |
| 2026-08-05 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Option exercise 10b5-1 | +17,000 | $24.79 | $421K | 93,756 |
| 2026-08-05 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Sale 10b5-1 | −17,000 | $55.00 | $935K | 76,756 |
| 2026-08-05 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −17,000 | 28,000 | ||
| 2026-08-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +2,250 | $5.35 | $12K | 159,791 |
| 2026-08-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −861 | $53.50 | $46K | 158,930 |
| 2026-08-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,389 | $54.09 | $75K | 157,541 |
| 2026-08-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −2,250 | 68,898 | ||
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 115,176 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −6,956 | $53.76 | $374K | 108,220 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,044 | $54.18 | $165K | 105,176 |
| 2026-08-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 216,827 | ||
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +16,198 | $2.03 | $33K | 469,445 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −11,783 | $55.52 | $654K | 457,662 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,415 | $55.93 | $247K | 453,247 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −756 | $55.52 | $42K | 133,459 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −244 | $55.96 | $14K | 133,215 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −622 | $55.54 | $35K | 133,593 |
Page 3 of 16 · 319 trades